Studies have reported that agonist-induced activation of DOR has been shown to increase BACE1 and γ-secretase activity in vitro in cells and in vivo in an AD mouse model leading to increased production of Aβ peptide (Figure 2) (Ni et al., 2006; Teng et al., 2010). Here, OPRD1 is linked to Alzheimer disease.